CPT1A and cancer: Further, we also find that the endocrine-resistant cell lines are highly sensitive to CPT1A inhibitor compared with primary cell lines, and endocrine treatment leads to upregulation of CPT1A, implying that cancer cells develop CPT1A-mediated pathway for cellular adaptation to the new environment.